Skip to main content
Latest news
Browse specialties
Breast cancer Genitourinary cancers Lung & thoracic cancers
In focus
Next-generation sequencing: Emerging biomarkers in thyroid and NSCLCs ctDNA and bladder cancer: Current understanding and beyond ROS1 fusion-positive NSCLC NSCLC driver mutations: Discussing the importance of RET, ALK and ROS1 alterations in NSCLC Early-stage NSCLC management: Surgery, targeted treatment and immunotherapy ALK fusion-positive NSCLC: International approaches to management RET fusion-positive NSCLC: Informing on the use of pralsetinib for patients with RET fusion-positive, advanced NSCLC COVID-19 & cancer
Conferences
SABCS 2022 ESMO 2022 2022 ASCO Annual Meeting
About us
Medicine Matters Oncology
EXTENDED SEARCH
Top

08-09-2019 | Lung cancer | Video | Article

Expert highlights from WCLC 2019

print
PRINT
insite
SEARCH

Advisory Board member Ross Camidge shares his top picks of the presentations at the 2019 World Conference on Lung Cancer, including the CASPIAN trial and the updated AMG 510 data (1:51).

External Content

Click Play to display this content and agree to third party cookies. (>)

Update your current cookie settings.

Read more about AMG 510 and the CASPIAN trial

print
PRINT

Related content

08-09-2019 | Non-small-cell lung cancer | Conference coverage | News

Treatment hope for KRAS-mutated advanced NSCLC
Image Credits